课题基金 / 基金详情

Rapid Diagnostic Assays for Human Caliciviruses

Rapid Diagnostic Assays for Human Caliciviruses
人类杯状病毒的快速诊断分析
批准号:
7250298
负责人:
Robert L. Atmar
金额:
$20.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Robert L. Atmar的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The focus of the studies proposed in this project is the development of rapid diagnostic assays for the detection of human caliciviruses. In Specific aim 1, we wilt develop broadly-reactive diagnostic reagents for human caliciviruses. Human caliciviruses are divided into two genera, Norovirus and Sapovirus, and within these genera are many genetically and antigenically distinct groups. We have previously identified monoclonal antibodies that recognize epitopes shared among the noroviruses. In addition, we and others have identified blood group antigens involved in binding to norovirus particles. We have recently confirmed the specificity of one of these antigens (Lewis d) for affinity purification of Norwalk virus. These and newly developed monoctonal antibodies and blood group carbohydrates will be characterized for use in the development of rapid, broadly-reactive diagnostic assays. In Specific aim 2, we will explore new rapid formats to detect human caliciviruses. High affinity, cross-reactive monoclonal antibodies characterized in specific aim 1 will be used in assays that require minimal sample preparation and yield a result in less than 30 minutes. Formats to be evaluated include those that have been used successfully for the detection of other human viruses and include traditional enzyme immunoassays, chromatographic immunoassays, latex agglutination assays, and dot-blot immunoassays. The assays will be tested against a panel of both human and animal caliciviruses and clinical specimens to determine sensitivity, specificity, positive and negative predictive values, and limits of detection. Developed assays will be validated by providing the diagnostic tests to other laboratories (e.g., CDC, state health labs) using RT-PCR assays to evaluate large numbers of specimens for human caliciviruses. In Specific aim 3, new approaches will be developed to correlate detection of human caliciviruses with their potential infectivity and susceptibility to inactivation. The inability to cultivate human caliciviruses in vitro has hampered assessment of their infectivity. A biosensoring system will utilize green fluorescent protein as a reporter signal that is expressed following the initiation of a viral infection in a transformed cell line. Different disinfection measures will be evaluated for both human and animal caliciviruses and the results will be correlated with those obtained by cell culture for the animal caliciviruses that are cultivatable.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rapid Diagnostics Assays and Antivirals for Noroviruses
  • 批准号:
    7774777
  • 项目类别:
  • 资助金额:
    $30.38万
  • 财政年份:
    2010
  • 负责人:
    Robert L. Atmar
  • 依托单位:
Pathogenesis and Antivirals for Noroviruses
  • 批准号:
    8855694
  • 项目类别:
  • 资助金额:
    $36.85万
  • 财政年份:
    2004
  • 负责人:
    Robert L. Atmar
  • 依托单位:
Pathogenesis and Antivirals for Noroviruses
  • 批准号:
    9292240
  • 项目类别:
  • 资助金额:
    $36.85万
  • 财政年份:
    2004
  • 负责人:
    Robert L. Atmar
  • 依托单位:
Pathogenesis & Antivirals for Noroviruses
  • 批准号:
    10450706
  • 项目类别:
  • 资助金额:
    $45.01万
  • 财政年份:
    2003
  • 负责人:
    Robert L. Atmar
  • 依托单位:
海外基金